EJIM High-impact articles

2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension by Kreutz (2024)

Natural history of metabolic dysfunction-associated steatotic liver disease by Lekakis (2024)

Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease by Mellemkjær (2024)

The role of adherence in patients with chronic diseases by Burnier (2024)

Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? by Portincasa (2024)

Non-invasive testing and risk-stratification in MASLD by Zoncapé (2024)

Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease by Armandi (2024)

Residual cardiovascular risk: when should we treat it? by Gomez-Delgado (2024)

Anticoagulation in atrial fibrillation. A large real-world update by Bo (2024)

From non-adherence to adherence: Can innovative solutions resolve a longstanding problem? by Kardas (2024)

Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy by Porcari (2024)

ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study by Pagura (2024)

Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid by Van Hooff (2024)

Pulmonary hypertension associated to left heart disease: Phenotypes and treatment by Madonna (2024)

Diet and physical exercise in elderly people with obesity: The state of the art by Battista (2024)

Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry by Mei (2024)

Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study by Alipour (2024)

Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients by Boriani (2024)

Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? by Boriani (2024)

Early prediction of ventilator-associated pneumonia with machine learning models: A systematic review and meta-analysis of prediction model performance by Frondelius (2024)

Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis by Kyriakoulis (2024)

TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD by Cané (2024)

Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm by Asteris (2024)

Artificial intelligence in scientific medical writing: Legitimate and deceptive uses and ethical concerns by Ramoni (2024)

The Long-COVID autonomic syndrome in hospitalized patients: A one-year prospective cohort study by Rigo (2024)

Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography by Santoro (2024)

Door-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis by Leung (2024)

Kidney function and other associated factors of sarcopenia in community-dwelling older adults: The SCOPE study by Moreno-Gonzalez (2024)

The lowest well tolerated blood pressure: A personalized target for all? by Verdecchia (2024)

Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology by Portincasa (2024)

Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins by Varricchi (2024)

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors combination therapy versus monotherapy and major adverse cardiovascular events: Do the benefits add up? by Karakasis (2024)